ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Nicox SA

Nicox SA (ALCOX)

0.2145
-0.0055
( -2.50% )
Updated: 23:58:30

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.2145
Bid
0.2135
Offer
0.2195
Volume
60,663
0.21 Day's Range 0.22
0.14 52 Week Range 0.4915
Market Cap
Previous Close
0.22
Open
0.21
Last Trade
2000
@
0.2145
Last Trade Time
23:58:18
Financial Volume
-
VWAP
-
Average Volume (3m)
376,453
Shares Outstanding
50,299,694
Dividend Yield
-
PE Ratio
-0.51
Earnings Per Share (EPS)
-0.42
Revenue
7.14M
Net Profit
-20.88M

About Nicox SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Antibes, Alpes-maritimes, Fra
Founded
-
Nicox SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALCOX. The last closing price for Nicox was 0.22 €. Over the last year, Nicox shares have traded in a share price range of 0.14 € to 0.4915 €.

Nicox currently has 50,299,694 shares in issue. The market capitalisation of Nicox is 11.07 € million. Nicox has a price to earnings ratio (PE ratio) of -0.51.

ALCOX Latest News

Nicox’s Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than Expected

Nicox’s Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than Expected Press ReleaseNicox’s Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than Expected Confirms...

Nicox : Recrutement de patients achevé plus tôt que prévu en Chine dans l’étude clinique de phase 3 Denali sur NCX 470

Nicox : Recrutement de patients achevé plus tôt que prévu en Chine dans l’étude clinique de phase 3 Denali sur NCX 470 Communiqué de presseNicox : Recrutement de patients achevé plus tôt que prévu...

Nicox annonce la publication de la partie adaptive de l’étude clinique de phase 3 Mont Blanc sur NCX 470

Nicox annonce la publication de la partie adaptive de l’étude clinique de phase 3 Mont Blanc sur NCX 470 Communiqué de presseNicox annonce la publication de la partie adaptive de l’étude clinique...

Nicox Announces Publication of the Adaptive Design Period of the NCX 470 Mont Blanc Phase 3 Trial

Nicox Announces Publication of the Adaptive Design Period of the NCX 470 Mont Blanc Phase 3 Trial Press Release Nicox Announces Publication of the Adaptive Design Period of the NCX 470 Mont Blanc...

Nicox : Point financier sur le troisième trimestre 2024 et résultats financiers du premier semestre 2024

Nicox : Point financier sur le troisième trimestre 2024 et résultats financiers du premier semestre 2024 Communiqué de presseNicox : Point financier sur le troisième trimestre 2024 et résultats...

Nicox Provides Third Quarter 2024 update and First Half 2024 Financial Results

Nicox Provides Third Quarter 2024 update and First Half 2024 Financial Results Press Release Nicox Provides Third Quarter 2024 update and First Half 2024 Financial Results  Topline results from...

Nicox et Soleus signent un accord de financement de 16,5 millions de dollars combinant la vente de redevances et un financement en fonds propres

Nicox et Soleus signent un accord de financement de 16,5 millions de dollars combinant la vente de redevances et un financement en fonds propres Communiqué de presse Nicox et Soleus signent un...

Nicox and Soleus Sign $16.5 million Royalty and Equity Financing

Nicox and Soleus Sign $16.5 million Royalty and Equity Financing Press Release Nicox and Soleus Sign $16.5 million Royalty and Equity Financing Gross proceeds of $15 million (€13.7 million) for...

Nicox et Glaukos signent un accord exclusif de recherche incluant une option de licence mondiale pour NCX 1728

Nicox et Glaukos signent un accord exclusif de recherche incluant une option de licence mondiale pour NCX 1728 Communiqué de presseNicox et Glaukos signent un accord exclusif de recherche incluant...

Nicox and Glaukos Sign Exclusive NCX 1728 Research and Global Licensing Option Agreement

Nicox and Glaukos Sign Exclusive NCX 1728 Research and Global Licensing Option Agreement Press Release Nicox and Glaukos Sign Exclusive NCX 1728 Research and Global Licensing Option Agreement...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.005-2.277904328020.21950.2240.206831740.21745462DE
4-0.0335-13.50806451610.2480.24850.206704480.22873977DE
120.040923.55990783410.17360.320.143764530.26021073DE
26-0.1055-32.968750.320.3250.142589160.2435132DE
52-0.1825-45.96977329970.3970.49150.141561780.26896145DE
156-0.3675-63.14432989690.5820.650.141329700.32059867DE
260-0.3675-63.14432989690.5820.650.141329700.32059867DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALDRVDrone Volt
0.33 €
(8,584.21%)
104.21k
ALNEVNeovacs
0.0003 €
(50.00%)
38.55M
ALSPWSpineway
0.1355 €
(28.19%)
3.92M
TRACTTeract SA
1.045 €
(23.23%)
121.87k
ALARFAdeunis
0.896 €
(20.75%)
17.22k
ALNMRNamR SA
0.45 €
(-17.88%)
2.53k
ALTAILighton
14.90 €
(-17.22%)
73.49k
ALEMSEuropean Medical Solutions
0.016 €
(-13.04%)
3.14k
ALEUPEuroplasma
0.083 €
(-12.63%)
2.13M
OSEOSE Immunotherapeutics
7.78 €
(-11.89%)
516.75k
ALNEVNeovacs
0.0003 €
(50.00%)
38.55M
ALCYBCybergun
0.0001 €
(0.00%)
22.78M
LATLatecoere
0.0087 €
(8.75%)
17.7M
BCPBanco Comercial Portugues SA
0.4425 €
(-1.18%)
15.49M
ALHPIHopium SA
0.009 €
(1.12%)
9.82M

Discussion

View Full Feed
midastouch017 midastouch017 5 minutes ago
RedHill Biopharma Awarded Judgment of Approximately $8 Million Plus Costs by New York Supreme Court

https://finance.yahoo.com/news/redhill-biopharma-awarded-judgment-approximately-120000878.html

RedHill has been awarded a judgment of approximately $8 million plus costs
RDHL
DiscoverGold DiscoverGold 6 minutes ago
S&P 500: Market optimism is so high, even bears are buying "Bull Market 2025" t-shirts, as the S&P 500 index has consistently risen in the six months following a significant milestone, with an above-average return of 7.7% since 1928
By: Isabelnet | December 2, 2024

• S&P 5
TrendTrade2016 TrendTrade2016 7 minutes ago
PDYN HERE COMES 8 BUCKS...NEXT RCAT
PDYN RCAT
peanutz peanutz 7 minutes ago
Showtime ! Let's get out of the trips ! Finally :-)
RDAR
TrendTrade2016 TrendTrade2016 8 minutes ago
SPAI READY FOR NEXT ROUND
SPAI
Hoghead7 Hoghead7 8 minutes ago
Holding over Friday's close throughout the day would obviously be a very good sign since we are already up over 115% from the recent low less than 3 weeks ago. However, we are barely above where support was prior to the RS announcement shortly before that low. $12 is also only = to $.40 pre-split.
FCEL
extrinsic55 extrinsic55 8 minutes ago
SGBX ask .73 Climbing
SGBX
RIGATONI RIGATONI 8 minutes ago
$10.35 news...

Applied Digital Closes $150 million Senior Secured Note With Macquarie Equipment Capital, Inc. to Refinance Existing Credit Facility With Former Senior Lender

https://finance.yahoo.com/news/applied-digital-closes-150-million-130000018.html
boi568 boi568 8 minutes ago
That's not necessarily true. Regulators in the U.S., for instance, are provided confidential business information all the time and must maintain its secrecy. A disclosure of CBI in that context would not be public.
AVXL
extrinsic55 extrinsic55 8 minutes ago
SGBX ask .73 Climbing
SGBX
extrinsic55 extrinsic55 8 minutes ago
SGBX ask .73 Climbing
SGBX
primecomm primecomm 9 minutes ago
Good Morning $RDAR
RDAR
budfoxfun budfoxfun 9 minutes ago
Revolutionary WaterLess Garden Product Tonight on Bloomberg’s New to the Street - CEO Tony Raynor Teams Up With Fishing Legend Jimmy Houston to Showcase Organic Solutions for Food Security https://finance.yahoo.com/news/sustainable-green-team-unveils-revolutionary-165500864.html?soc_src=social-sh&so
SGTM
StockItOut StockItOut 10 minutes ago
Your bet you made everyone's business by posting it here.

You did lose the bet. There are SEC filings that show XTI shares were issued to Xeriant by XTI. Your bet claimed Xeriant would never own a share of XTI common stock. You lost your bet.

You have yet to provide a
XTIA
IAmTopG IAmTopG 10 minutes ago
You are talking about 30x from here. Definitely would love to see that. Would be my saving grace for this yr
AZRH
930 930 10 minutes ago
I'll take a .50 or more jump.
KULR
Frankher Frankher 11 minutes ago
In the dynamic telecommunications landscape, the integration of artificial intelligence (AI) is not just a trend; it is a crucial competitive advantage.

iQSTEL leads this transformation by implementing AI solutions that optimize network management, reduce operational costs by up to 20
IQST
Sodapop42 Sodapop42 11 minutes ago
Ill try to figure out some way of uploading it here if I can.
PHIL
peanutz peanutz 11 minutes ago
💯 % agree . Ravens just need to sneak in . Very talented club !
IGPK
peanutz peanutz 12 minutes ago
This is so undervalued! Is today 10 dollar break ? Sleeping giant here
SOUN
RIGATONI RIGATONI 13 minutes ago
$2.18 new high ~Rig
RIGATONI RIGATONI 14 minutes ago
"Moving forward, all new financing will be derived from...


equity or instruments with fixed-price features, eliminating the need for floorless convertible securities and enhancing shareholder value.
powerwalker powerwalker 14 minutes ago
Good morning, Roger:

Did the doctor's office get things right, so you are now on Ohtuvayre?

If so, let us know how it is helping.
VRNA
misterfishman misterfishman 14 minutes ago
true but the ravens would have won if tucker just made 2 of the 3 kicks he missed, and i don't think the chiefs will 3 peat this season
IGPK
infamous infamous 14 minutes ago
THATS WHY I JUST STARTED NOW! BETTER NOW THAN NEVER

Your Recent History

Delayed Upgrade Clock